Inhibition of cell proliferation by the Mad1 transcriptional repressor

Molecular and Cellular Biology

Volumn 16, Issue 6, 1996, Pages 2796-2801

  Roussel, Martine F ^a   Ashmun, Richard A ^a   Sherr, Charles J ^a   Eisenman, Robert N ^b   Ayer, Donald E ^b,c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE ZIPPER PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN INDUCTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0029905346     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.6.2796     Document Type: Article

References (44)

1. Amati, B., and H. Land. 1994. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr. Opin. Genet. Dev. 4:102-108.
2. Ayer, D. E., and R. N. Eisenman. 1993. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev. 7:2110-2119.
3. Ayer, D. E., L. Kretzner, and R. N. Eisenman. 1993. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:211-222.
4. Ayer, D. E., Q. A. Lawrence, and R. N. Eisenman. 1995. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80:767-776.
5. Baldin, V., J. Lukas, M. J. Marcote, M. Pagano, and G. Draetta. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812-821.
6. Blackwood, E. M., L. Kretzner, and R. N. Eisenman. 1992. Myc and Max function as a nucleoprotein complex. Curr. Opin. Genet. Dev. 2:227-235.
7. Cerni, C., K. Bousset, C. Seelos, H. Burkhardt, M. Henriksson, and B. Luscher. 1995. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. Oncogene 11:587-596.
8. Chen, C., and H. Okayama. 1987. High-efficiency transfection of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
9. Chen, J., T. Willingham, L. R. Margraf, N. Schreiber-Agus, R. A. DePinho, and P. D. Nisen. 1995. Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumor cells. Nat. Med. 1:638-643.
10. Delgado, M. D., A. Lerga, M. Canelles, M. T. Gomez-Casares, and J. Leon. 1995. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells. Oncogene 10:1659-1665.
11. Eagle, L. R., X. Yin, A. R. Brothman, B. J. Williams, N. B. Atkin, and E. V. Prochownik. 1995. Mutation of the MXI1 gene in prostate cancer. Nat. Genet. 9:249-255.
12. 11a. Eilers, M., S. Schirm, and J. M. Bishop. 1991. The MYC protein activates transcription of the a-prothymosin gene. EMBO J. 10:133-141.
13. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
14. 1. Mol. Cell. Biol. 8:1614-1624.
15. Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021.
16. Hann, S. R., C. B. Thompson, and R. N. Eisenman. 1985. c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature (London) 314:366-369.
17. Heikkila, R., G. Schwab, E. Wickstrom, S. L. Loke, D. H. Pluznik, R. Watt, and L. M. Neckers. 1987. c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1. Nature (London) 328:445-449.
18. Hirai, H., M. F. Roussel, J.-Y. Kato, R. A. Ashmun, and C. J. Sherr. 1995. Novel Ink4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15:2672-2681.
19. Hurlin, P. J., K. P. Foley, D. E. Ayer, R. N. Eisenman, D. Hanahan, and J. M. Arbeit. 1995. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Oncogene 11:2487-2501.
20. Hurlin, P. J., C. Quéva, P. J. Koskinen, E. Steingrímsson, D. E. Ayer, N. G. Copeland, N. A. Jenkins, and R. N. Eisenman. 1995. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-Myc-dependent transformation and are expressed during neural and epidermal differentiation. EMBO J. 14:5646-5659.
21. Koskinen, P. J., D. E. Ayer, and R. N. Eisenman. 1995. Repression of Myc-Ras co-transformation by Mad is mediated by multiple protein-protein interactions. Cell Growth Differ. 6:623-629.
22. Lahoz, E. G., L. Xu, N. Schreiber-Agus, and R. A. DePinho. 1994. Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. Proc. Natl. Acad. Sci. USA 91:5503-5507.
23. Larsson, L.-G., M. Pettersson, F. Öberg, K. Nilsson, and B. Luscher. 1994. Expression of mad, mxi1, max, and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene 9:1247-1252.
24. Look, A. T., S. L. Melvin, L. K. Brown, M. E. Dockter, P. K. Roberson, and S. B. Murphy. 1984. Quantitative variation of the common acute lymphoblastic leukemia antigen (gp100) on leukemic marrow blasts. J. Clin. Invest. 73:1617-1628.
25. Luscher, B., and R. N. Eisenman. 1992. Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb. J. Cell Biol. 118:775-784.
26. Meichle, A., A. Philipp, and M. Eilers. 1992. The functions of Myc proteins. Biochim. Biophys. Acta 1114:129-146.
27. Muller, A. J., J. C. Young, A.-M. Pendergast, M. Pondel, N. R. Landau, D. R. Littman, and O. N. Witte. 1991. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell. Biol. 11:1785-1792.
28. Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
29. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
30. INK4h genes. Oncogene 11:635-645.
31. Quelle, D. E., R. A. Ashmun, S. A. Shurtleff, J. Kato, D. Bar-Sagi, M. F. Roussel, and C. J. Sherr. 1993. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7:1559-1571.
32. 30a. Quéva, C. Unpublished data.
33. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1669-1679.
34. Roussel, M. F., J. L. Cleveland, S. A. Shurtleff, and C. J. Sherr. 1991. Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling. Nature (London) 353:361-363.
35. Roussel, M. F., T. J. Dull, C. W. Rettenmier, A. Ralph, A. Ullrich, and C. J. Sherr. 1987. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature (London) 325:549-552.
36. Roussel, M. F., A. M. Theodoras, M. Pagano, and C. J. Sherr. 1995. Rescue of defective mitogenic signalling by D-type cyclins. Proc. Natl. Acad. Sci. USA 92:6837-6841.
37. Schreiber-Agus, N., L. Chin, K. Chen, K. Torres, G. Rao, P. Guisa, A. I. Skoultchi, and R. A. DePinho. 1995. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with the homolog of the yeast repressor SIN3. Cell 80:777-786.
38. Seth, A., S. Gupta, and R. J. Davis. 1993. Cell cycle regulation of the c-Myc transcriptional activation domain. Mol. Cell. Biol. 13:4125-4136.
39. Shibuya, H., M. Yoneyama, J. Ninomiya-Tsuji, K. Matsumoto, and T. Taniguchi. 1992. IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell 70:57-67.
40. Thompson, C. B., P. B. Challoner, P. E. Neiman, and M. Groudine. 1985. Levels of c-myc mRNA are invariant throughout the cell cycle. Nature (London) 314:363-366.
41. Vastrik, I., A. Kaipainen, T.-L. Penttila, A. Lymboussakis, R. Alitalo, M. Parvinen, and K. Alitalo. 1995. Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro. J. Cell Biol. 128:1197-1208.
42. Vogelstein, B., and K. W. Kinzler. 1992. p53 function and dysfunction. Cell 70:523-526.
43. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
44. Zervos, A. S., J. Gyuris, and R. Brent. 1993. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72:223-232.